Home Amines 157832-56-9
157832-56-9,MFCD00492838
Catalog No.:AA001MKK

157832-56-9 | N-(5-(Diethylamino)-1-phenylpentyl)-4-nitrobenzamide hydrochloride

Pack Size
Purity
Availability
Price(USD)
Quantity
  
500mg
1 week  
$427.00   $299.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA001MKK
Chemical Name:
N-(5-(Diethylamino)-1-phenylpentyl)-4-nitrobenzamide hydrochloride
CAS Number:
157832-56-9
Molecular Formula:
C22H30ClN3O3
Molecular Weight:
419.9449
MDL Number:
MFCD00492838
SMILES:
CCN(CCCCC(c1ccccc1)NC(=O)c1ccc(cc1)[N+](=O)[O-])CC.Cl
Properties
Computed Properties
 
Complexity:
462  
Covalently-Bonded Unit Count:
2  
Heavy Atom Count:
29  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
10  
Undefined Atom Stereocenter Count:
1  

Literature

Title: Potential artefacts in proteome analysis of plasma of Gaucher patients due to protease abnormalities.

Journal: Clinica chimica acta; international journal of clinical chemistry 20081001

Title: [Nibentan in arresting acute atrial fibrillation: risk or benefit?].

Journal: Terapevticheskii arkhiv 20080101

Title: [Effect of nibentan on dispersion of repolarization of ventricular myocardium in the rabbit].

Journal: Kardiologiia 20080101

Title: [Comparative study of the electrophysiological properties of class iii medicinals (cardiocyclide, nibentan, sotalol) and evaluation of their efficacy in atrial fibrillation produced by auricular and vagal stimulation].

Journal: Eksperimental'naia i klinicheskaia farmakologiia 20070101

Title: [The efficacy and safety of nibentan for pharmacological cardioversion in patients with persistent atrial fibrillation and flutter: the role of dose limitation and magnesium sulfate administration].

Journal: Kardiologiia 20070101

Title: [Comparison of the efficacy and safety of electrical cardioversion and pharmacological cardioversion with nibentan in patients with persisting atrial fibrillation and flutter].

Journal: Vestnik Rossiiskoi akademii meditsinskikh nauk 20070101

Title: [Effect of the class III antiarrhythmic drug nibentan in vagotonic atrial fibrillation].

Journal: Eksperimental'naia i klinicheskaia farmakologiia 20060101

Title: Myocardial contractility after in vitro treatment with class III antiarrhythmic drug Nibentan.

Journal: Bulletin of experimental biology and medicine 20060101

Title: [Nibentan -- a drug for pharmacological cardioversion of persistent atrial fibrillation].

Journal: Kardiologiia 20050101

Title: [Cardiac effects of the class III antiarrhythmic drugs amiodarone and nibentan].

Journal: Fiziologiia cheloveka 20050101

Title: [Comparative study of electrophysiological mechanisms of anti-arrhythmia III class agents, cardiocyclide, nibentan, and sotalol during experimental myocardial infarction and sympathetic stimulation].

Journal: Eksperimental'naia i klinicheskaia farmakologiia 20030101

Title: [Electrophysiological effects and mechanisms of antiarrhythmic action of nibentan in patients with paroxysmal arrhythmias].

Journal: Kardiologiia 20030101

Title: [Novel antiarrhythmic class III drug nibentan: from experimental studies to clinical practice].

Journal: Kardiologiia 20030101

Title: [Development of original Russian antiarrhythmic drugs of the 3rd class].

Journal: Vestnik Rossiiskoi akademii meditsinskikh nauk 20030101

Title: Effect of class III antiarrhythmic preparation nibentan on extrasystolic and post-extrasystolic contraction of rat papillary muscle.

Journal: Bulletin of experimental biology and medicine 20020701

Title: [Comparative study of the anti-arrhythmic activity of cardiocyclide and nibentan in hypersympathotonia and acute myocardial ischemia].

Journal: Eksperimental'naia i klinicheskaia farmakologiia 20020101

Title: [Effect of mexidol, emoxypine, and dimephosphon on electrophysiological effects of nibentan].

Journal: Eksperimental'naia i klinicheskaia farmakologiia 20020101

Title: [Effect of a nibentan derivative LKhT53-91 on the heart electrophysiological parameters].

Journal: Eksperimental'naia i klinicheskaia farmakologiia 20020101

Title: [The effect of novel class III anti-arrhythmia agents cardiocyclide and nibentan during activation of cardiac beta-adrenoreceptors].

Journal: Eksperimental'naia i klinicheskaia farmakologiia 20020101

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 157832-56-9
Tags:157832-56-9 Molecular Formula|157832-56-9 MDL|157832-56-9 SMILES|157832-56-9 N-(5-(Diethylamino)-1-phenylpentyl)-4-nitrobenzamide hydrochloride